MDK and hepatocellular carcinoma: MDK was elevated in 54% of the HCC patients at the time of diagnosis and, remarkably, MDK was elevated 6 months prior to diagnosis in 67% of patients, suggesting MDK’s role in pre-clinical HCC diagnosis.